Pharmaceuticals BRIC (Brazil, Russia, India, China) Industry Guide 2013-2022
Region:Global
Product Code:MLIG180033-04
June 2018
113
About the Report
Pharmaceuticals BRIC (Brazil, Russia, India, China) Industry Guide 2013-2022
Summary
The BRIC Pharmaceuticals industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2013-17, and forecast to 2022). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Synopsis
Essential resource for top-line data and analysis covering the BRIC pharmaceuticals market. Includes market size data, textual and graphical analysis of market growth trends and leading companies.
Key Highlights
- Brazil, Russian Federation, India and China (BRIC) are the emerging and fast growing countries within the pharmaceuticals industry and had a total market value of USD 192.3 billion in 2017. India was the fastest growing country with a CAGR of 15.9% over the 2013-17 period.
- Within the pharmaceuticals industry, China is the leading country among the BRIC nations with market revenues of USD 108.3 billion in 2017. This was followed by India, Brazil and Russia with a value of USD 35.2, USD 26.1, and USD 22.7 billion, respectively.
- China is expected to lead the pharmaceuticals industry in the BRIC nations with a value of USD 173.1 billion in 2022, followed by India, Russia, Brazil with expected values of USD 70.2, USD 41.3 and USD 31.0 billion, respectively.
Scope
- Save time carrying out entry-level research by identifying the size, growth, and leading players in the BRIC pharmaceuticals market
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the BRIC pharmaceuticals market
- Leading company profiles reveal details of key pharmaceuticals market players' BRIC operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the BRIC pharmaceuticals market with five year forecasts
- Compares data from Brazil, Russia, India, and China, alongside individual chapters on each country
Reasons to buy
- What was the size of the BRIC pharmaceuticals market by value in 2017?
- What will be the size of the BRIC pharmaceuticals market in 2022?
- What factors are affecting the strength of competition in the BRIC pharmaceuticals market?
- How has the market performed over the last five years?
- Who are the top competitors in the BRIC pharmaceuticals market?
Scope of the Report
Products
Companies
Table of Contents
Table of Contents
BRIC Pharmaceuticals 10
Industry Outlook 10
Introduction 13
What is this report about? 13
Who is the target reader? 13
How to use this report 13
Definitions 13
Pharmaceuticals in Brazil 14
Market Overview 14
Market Data 15
Market Segmentation 16
Market outlook 18
Five forces analysis 19
Pharmaceuticals in China 27
Market Overview 27
Market Data 28
Market Segmentation 29
Market outlook 31
Five forces analysis 32
Macroeconomic indicators 41
Macroeconomic indicators 43
Pharmaceuticals in India 45
Market Overview 45
Market Data 46
Market Segmentation 47
Market outlook 49
Five forces analysis 50
Macroeconomic indicators 59
Pharmaceuticals in Russia 61
Market Overview 61
Market Data 62
Market Segmentation 63
Market outlook 65
Five forces analysis 66
Macroeconomic indicators 76
Company Profiles 78
Leading Companies 78
Appendix 111
Methodology 111
About MarketLine 112
Research Methodology
Why Buy From Us?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.